Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» US Spinraza sales cause concern among Biogen investors
US Spinraza sales cause concern among Biogen investors
US Spinraza sales cause concern among Biogen investors
Submitted by
admin
on October 25, 2017 - 9:40am
Source:
Biopharma Dive
News Tags:
Biogen
Spinraza
spinal muscular atrophy
investors
Headline:
US Spinraza sales cause concern among Biogen investors
Do Not Allow Advertisers to Use My Personal information
